The global ADCA market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The high purity type segment is expected to account for the largest share of the global ADCA market in terms of revenue, followed by low purity type and cefalexin segment. The high purity type segment is projected to account for a share of over 50% in terms of revenue by 2030.
North America accounted for the largest share in terms of revenue and volume consumption in 2018, followed by Europe and Asia Pacific respectively. North America was also projected to be the fastest-growing region with an estimated CAGR of 6%.
Some Of The Growth Factors Of This Market:
- The 7-ADCA market is expected to grow due to the increasing demand for anti-inflammatory drugs and painkillers in emerging economies such as China, India, and Brazil.
- Increasing prevalence of chronic diseases such as arthritis, cancer, and diabetes will also drive the growth of this market during the forecast period.
- Increasing awareness about 7-ADCA among consumers will also drive this market.
- Increasing research on new drug formulations that are more effective than existing ones will also fuel this market.
Industry Growth Insights published a new data on “7-ADCA Market”. The research report is titled “7-ADCA Market research by Types (High Purity Type, Low Purity Type), By Applications (Cefalexin, Cefradine, Cefadroxil), By Players/Companies DSM Sinochem Pharmaceuticals, Jigs Chemical, Zhejiang New Donghai Pharmaceutical, Lupin Pharmaceuticals, ACS Dobfar, Antibioticos, Aurobindo Pharma, Bristol-Myers Squibb, Fersinsa Gist Brocades, Orchid Pharma, Ranbaxy Laboratories, Shandong New Time Pharmaceutical, Shanghai Whyte Asia Pioneer Pharmaceuticals, Biocraft Laboratories, Techco Chemical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
7-ADCA Market Research Report
By Type
High Purity Type, Low Purity Type
By Application
Cefalexin, Cefradine, Cefadroxil
By Companies
DSM Sinochem Pharmaceuticals, Jigs Chemical, Zhejiang New Donghai Pharmaceutical, Lupin Pharmaceuticals, ACS Dobfar, Antibioticos, Aurobindo Pharma, Bristol-Myers Squibb, Fersinsa Gist Brocades, Orchid Pharma, Ranbaxy Laboratories, Shandong New Time Pharmaceutical, Shanghai Whyte Asia Pioneer Pharmaceuticals, Biocraft Laboratories, Techco Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global 7-ADCA Market Report Segments:
The global 7-ADCA market is segmented on the basis of:
Types
High Purity Type, Low Purity Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cefalexin, Cefradine, Cefadroxil
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- DSM Sinochem Pharmaceuticals
- Jigs Chemical
- Zhejiang New Donghai Pharmaceutical
- Lupin Pharmaceuticals
- ACS Dobfar
- Antibioticos
- Aurobindo Pharma
- Bristol-Myers Squibb
- Fersinsa Gist Brocades
- Orchid Pharma
- Ranbaxy Laboratories
- Shandong New Time Pharmaceutical
- Shanghai Whyte Asia Pioneer Pharmaceuticals
- Biocraft Laboratories
- Techco Chemical
Highlights of The 7-ADCA Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- High Purity Type
- Low Purity Type
- By Application:
- Cefalexin
- Cefradine
- Cefadroxil
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 7-ADCA Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
7-ADCA is an abbreviation for 7-amino-4,5,6,7,8-tetrahydrocyclopenta[a]pyrazolo[3,4-c]pyrimidine.
Some of the major players in the 7-adca market are DSM Sinochem Pharmaceuticals, Jigs Chemical, Zhejiang New Donghai Pharmaceutical, Lupin Pharmaceuticals, ACS Dobfar, Antibioticos, Aurobindo Pharma, Bristol-Myers Squibb, Fersinsa Gist Brocades, Orchid Pharma, Ranbaxy Laboratories, Shandong New Time Pharmaceutical, Shanghai Whyte Asia Pioneer Pharmaceuticals, Biocraft Laboratories, Techco Chemical.
The 7-adca market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. 7-ADCA Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. 7-ADCA Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. 7-ADCA Market - Supply Chain
4.5. Global 7-ADCA Market Forecast
4.5.1. 7-ADCA Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. 7-ADCA Market Size (000 Units) and Y-o-Y Growth
4.5.3. 7-ADCA Market Absolute $ Opportunity
5. Global 7-ADCA Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. 7-ADCA Market Size and Volume Forecast by Type
5.3.1. High Purity Type
5.3.2. Low Purity Type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global 7-ADCA Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. 7-ADCA Market Size and Volume Forecast by Application
6.3.1. Cefalexin
6.3.2. Cefradine
6.3.3. Cefadroxil
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global 7-ADCA Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. 7-ADCA Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global 7-ADCA Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. 7-ADCA Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global 7-ADCA Demand Share Forecast, 2019-2029
9. North America 7-ADCA Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America 7-ADCA Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America 7-ADCA Market Size and Volume Forecast by Application
9.4.1. Cefalexin
9.4.2. Cefradine
9.4.3. Cefadroxil
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America 7-ADCA Market Size and Volume Forecast by Type
9.7.1. High Purity Type
9.7.2. Low Purity Type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America 7-ADCA Demand Share Forecast, 2019-2029
10. Latin America 7-ADCA Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America 7-ADCA Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America 7-ADCA Market Size and Volume Forecast by Application
10.4.1. Cefalexin
10.4.2. Cefradine
10.4.3. Cefadroxil
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America 7-ADCA Market Size and Volume Forecast by Type
10.7.1. High Purity Type
10.7.2. Low Purity Type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America 7-ADCA Demand Share Forecast, 2019-2029
11. Europe 7-ADCA Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe 7-ADCA Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe 7-ADCA Market Size and Volume Forecast by Application
11.4.1. Cefalexin
11.4.2. Cefradine
11.4.3. Cefadroxil
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe 7-ADCA Market Size and Volume Forecast by Type
11.7.1. High Purity Type
11.7.2. Low Purity Type
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe 7-ADCA Dmand Share, 2019-2029
12. Asia Pacific 7-ADCA Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific 7-ADCA Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific 7-ADCA Market Size and Volume Forecast by Application
12.4.1. Cefalexin
12.4.2. Cefradine
12.4.3. Cefadroxil
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific 7-ADCA Market Size and Volume Forecast by Type
12.7.1. High Purity Type
12.7.2. Low Purity Type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific 7-ADCA Demand Share, 2019-2029
13. Middle East & Africa 7-ADCA Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa 7-ADCA Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa 7-ADCA Market Size and Volume Forecast by Application
13.4.1. Cefalexin
13.4.2. Cefradine
13.4.3. Cefadroxil
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa 7-ADCA Market Size and Volume Forecast by Type
13.7.1. High Purity Type
13.7.2. Low Purity Type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa 7-ADCA Demand Share, 2019-2029
14. Competition Landscape
14.1. Global 7-ADCA Market: Market Share Analysis
14.2. 7-ADCA Distributors and Customers
14.3. 7-ADCA Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. DSM Sinochem Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Jigs Chemical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Zhejiang New Donghai Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lupin Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ACS Dobfar
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Antibioticos
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aurobindo Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bristol-Myers Squibb
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fersinsa Gist Brocades
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Orchid Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ranbaxy Laboratories
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Shandong New Time Pharmaceutical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Shanghai Whyte Asia Pioneer Pharmaceuticals
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Biocraft Laboratories
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Techco Chemical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
